小林化工株式会社が承認を有する医薬品の承認申請に関する不適切行為への対応について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_18128.html小林化工株式会社が承認を有する医薬品の承認申請に関する不適切行為への対応について｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces that Kobayashi Pharmaceutical Co., Ltd. engaged in improper conduct related to drug approval applications for multiple pharmaceuticals under its approval. Through field investigations and company reports, the facts were confirmed. The Ministry will impose strict administrative sanctions following administrative procedures. The improper conduct involved falsifying stability test implementation dates and using manufacturing methods different from those stated in the approval application. However, post-approval stability tests confirmed that all affected drugs showed no quality, efficacy, or safety issues.
